Merck and Nano-C, Inc. Jointly Develop New-Generation Materials for Organic Photovoltaic Applications
Merck KGaA announced it has signed a collaboration agreement with Nano-C, Inc.. Both companies aim to jointly develop and commercialize advanced semiconducting materials and formulations for applications in organic photovoltaics (OPV). Additionally, adding to its base of OPV materials, Merck will distribute PCBM fullerene derivative products, a family of semiconducting materials commonly used in OPV applications.
The collaboration will target the development of material systems to go beyond the performance limitations of current-generation OPV materials. It will bring together Merck’s extensive experience with organic semiconducting materials and Nano-C’s unique know-how and intellectual property in fullerene derivatives. Novel material concepts produced using intelligent design will enable power conversion efficiency values in excess of 10%, thereby creating new and broader market interest in organic photovoltaic technologies.
“Nano-C’s world-leading expertise and IP in fullerene technology complements our extensive material portfolio in organic electronics and will enable the rapid development of commercially attractive products for the exciting area of organic photovoltaics,” said Dr. Klaus Bofinger, Head of Advanced Technologies at Merck.
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Agilent Technologies, BIA Separations GmbH sign agreement giving Agilent access to BIA Separations' bio-monolitic technology

How Do Hay Fever Medications Work?
Roche and Schering-Plough resolve peginterferon patent disputes
BASF raises prices for methylamines and methylamine derivatives
Novartis submits supplemental NDA with US FDA for Glivec® for treatment of certain GI tumors
Sabo SpA appoints Biesterfeld Spezialchemie as distribution partner for HALS
A. Schulman Appoints Dennis Smith Director of New Business Applications

Space determines the arrangement - Researchers study historical developments of the periodic system of chemical elements
